Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.

Jim Cramer says many companies aren't prepared for extended shutdowns and they may not be able to get the credit they need to survive.

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

Jim Cramer focuses on Roku, Sierra Wireless, Visa, Cimarex Energy, First Solar, Halozyme Therapeutics.

Elon Musk has closed out his margin loans, linked to Tesla shares, and pledged another $6.25 billion in equity to fund his $44 billion takeover of the social media website.

Nvidia stock is being bought on the dip. Here's how traders should approach it now.

"While macroeconomic pressures on consumer spending increased during the quarter, our customers continued to shop," said CEO Jeff Gennette.

"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.